ENCAPIA

This brand name is authorized in Cyprus, Estonia, Romania.

Active ingredients

The drug ENCAPIA contains one active pharmaceutical ingredient (API):

`1`	Entacapone UNII `4975G9NM6T` - ENTACAPONE
	Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa.
	Read more about Entacapone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BX02	Entacapone	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1549649, 1549694, 1549706, 1549717
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59891001, W59891002, W59891003, W59891004, W59891005, W59891006, W59891007, W59891008, W59891009

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.